Publications
Prevalence of hidradenitis suppurativa in a Turkish population: validation of a screening questionnaire in Istanbul, Turkey
Vural S, Baskurt D, Özcanlı A, Bozkurt EG, Danacı S, Sarıoğlu S, Berrak YH, Başkan A, Yaylı S, Bouazzi D, Medianfar CE, Christensen R, Jemec GBE
Date: 2024
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis
Bouazzi D, Andersen RK, Vinding GR, Medianfar CE, Nielsen SM, Saunte DML, Chandran NS, van der Zee HH, Zouboulis CC, Benhadou F, Villumsen B, Alavi A, Ibekwe PU, Hamzavi IH, Ingram JR, Naik HB, Garg A, Boer J, Christensen R, Jemec GBE.
Introduction: Data concerning the global burden of hidradenitis suppurativa (HS) are limited. Reported prevalence estimates vary between 0.0003% and 4.1%, and data from various geographical regions are still to be collected.
Date: 2024
Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria
Anaba EL, Bouazzi D, Ajayi PV, Aro OO, Boer J, Jemec GBE.
Background: Epidemiologic hidradenitis suppurativa (HS) studies from Africa are lacking. This study aimed at uncovering the prevalence of HS in Lagos, Nigeria, to validate an HS screening questionnaire, and to contribute to the Global Hidradenitis Suppurativa Atlas (GHiSA).
Date: 2023
Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting
Botvid SHC, Storgaard Hove L, Bouazzi D, Kjærsgaard Andersen R, Francis Thomsen S, Saunte DM, Jemec GBE.
Date: 2023
Prevalence of Hidradenitis Suppurativa in Berekum, Ghana
Hagan PG, Bouazzi D, Nyarko G, Dartey ES, Nunoo-Ghartey KB, Nkum D, Ansu P, Boakye JY, Andersen RK, Boer J, Jemec GBE.
Date: 2022